Evaluation of a low‐dose desoxycorticosterone pivalate treatment protocol for long‐term management of dogs with primary hypoadrenocorticism

Abstract Background Lowering the dose of desoxycorticosterone pivalate (DOCP) for the treatment of dogs with primary hypoadrenocorticism (PH) decreases costs and could lead to increased owner motivation to treat their affected dogs. Objective To evaluate the efficacy of a low‐dose DOCP treatment pro...

Full description

Bibliographic Details
Main Authors: Nadia S. Sieber‐Ruckstuhl, Claudia E. Reusch, Nathalie Hofer‐Inteeworn, Claudia Kuemmerle‐Fraune, Claudia Müller, Regina Hofmann‐Lehmann, Felicitas S. Boretti
Format: Article
Language:English
Published: Wiley 2019-05-01
Series:Journal of Veterinary Internal Medicine
Subjects:
Online Access:https://doi.org/10.1111/jvim.15475